New images of the virus from researchers at the University of Wisconsin–Madison may hold the key to preventing or slowing RSV infections. RSV is of the greatest concern for young children ...
The FDA has started a review of MSD's respiratory syncytial virus (RSV) antibody clesrovimab, with a verdict due in the middle of next year. If approved by the 10th June action date, clesrovimab ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback